AG advises CJEU to uphold €94 million pay-for-delay fine

The advocate general has recommended that the Court of Justice of the European Union (CJEU) uphold an almost €94 million ($106.5 million) fine imposed on Lundbeck for its pay-for-delay scheme.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

EC fines Teva €60.5m over pay-for-delay deal

27 November 2020 The European Commission has fined Teva and its subsidiary Cephalon €60.5 million for agreeing to delay a cheaper generic version of sleep disorder drug modafinil.

Europe

Lundbeck loses €150m pay-for-delay appeal

30 March 2021 Lundbeck has lost an appeal to the Court of Justice of the European Union (CJEU) to waive €150 million ($176 million) in fines levied against itself and a group of five generics manufacturers over ‘pay-for-delay’ deals for its antidepressant generics.

Generics

Fifth circuit denies Impax pay-for-delay petition

15 April 2021 The Fifth Circuit of the Court of Appeals has denied a petition from Impax Laboratories to overturn a decision finding Impax engaged in an illegal pay-for-delay settlement with Endo Pharmaceuticals.

More on this story

Big Pharma

EC fines Teva €60.5m over pay-for-delay deal

27 November 2020 The European Commission has fined Teva and its subsidiary Cephalon €60.5 million for agreeing to delay a cheaper generic version of sleep disorder drug modafinil.

Europe

Lundbeck loses €150m pay-for-delay appeal

Generics

Fifth circuit denies Impax pay-for-delay petition

More on this story

Big Pharma

EC fines Teva €60.5m over pay-for-delay deal

27 November 2020 The European Commission has fined Teva and its subsidiary Cephalon €60.5 million for agreeing to delay a cheaper generic version of sleep disorder drug modafinil.

Europe

Lundbeck loses €150m pay-for-delay appeal

Generics

Fifth circuit denies Impax pay-for-delay petition